Karyopharm Therapeutics Inc (KPTI)

Feb 12, 2026

Karyopharm Therapeutics Inc Shares Rise After Q4 2025 Results - AlphaStreet News

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc (KPTI) Q4 2025 Earnings Call Highlights: Revenue Growth Amidst Financial Challenges - GuruFocus

Feb 12, 2026

Feb 12, 2026

Karyopharm reports fourth quarter and full year 2025 financial results and highlights recent company progress - marketscreener.com

Feb 12, 2026

Feb 12, 2026

Karyopharm Q4 2025 slides: Revenue growth amid pivotal myelofibrosis readout preparations - Investing.com

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc (KPTI) Q4 2025 Earnings Call Highlig - GuruFocus

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) Announces Earnings Results, Misses Expectations By $3.45 EPS - MarketBeat

Feb 12, 2026

Feb 12, 2026

Page not foundAirwhon - MarketBeat

Feb 12, 2026

Feb 12, 2026

Karyopharm (KPTI) Q4 2025 Earnings Call Transcript - AOL.com

Feb 12, 2026

Feb 12, 2026

Earnings call transcript: Karyopharm sees 11.8% revenue rise in Q4 2025 - Investing.com India

Feb 12, 2026

Feb 12, 2026

Karyopharm Q4 2025 slides: Revenue growth amid pivotal myelofibrosis readout preparations By Investing.com - Investing.com India

Feb 12, 2026

Feb 12, 2026

KPTI: Q4 revenue up, operating loss improved, pivotal phase 3 data in myelofibrosis due soon - TradingView

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics: Fourth Quarter Earnings Overview - Bitget

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics Inc (NASDAQ:KPTI) Reports Q4 Revenue Miss and Wider Loss, Stock Falls in Pre-Market - ChartMill

Feb 12, 2026

Feb 12, 2026

KARYOPHARM THERAPEUTICS ($KPTI) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 12, 2026

Feb 12, 2026

Karyopharm Therapeutics: Q4 Earnings Snapshot - WWLTV.com

Feb 12, 2026

Feb 12, 2026

Karyopharm Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Company Progress - PR Newswire

Feb 12, 2026

Feb 11, 2026

Karyopharm Reports 2025 Financials and 2026 Outlook - Intellectia AI

Feb 11, 2026

Feb 11, 2026

Uncovering Potential: Karyopharm Therapeutics's Earnings Preview - Benzinga

Feb 11, 2026

Feb 09, 2026

Investment Report: Can Karyopharm Therapeutics Inc disrupt its industry2025 Earnings Surprises & Low Risk High Reward Ideas - baoquankhu1.vn

Feb 09, 2026

Feb 09, 2026

Stock Market Recap: Can Karyopharm Therapeutics Inc disrupt its industryTrade Performance Summary & Risk Managed Investment Entry Signals - baoquankhu1.vn

Feb 09, 2026

Feb 07, 2026

Karyopharm Therapeutics (KPTI) Expected to Announce Earnings on Thursday - MarketBeat

Feb 07, 2026

Feb 06, 2026

Karyopharm Therapeutics (KPRX): Tiny Cancer Stock, Massive Drama – Is It Worth Your Money? - AD HOC NEWS

Feb 06, 2026

Feb 05, 2026

Cantor Fitzgerald Initiates Coverage on KPTI with Overweight Rat - GuruFocus

Feb 05, 2026

Feb 05, 2026

Cantor Fitzgerald initiates Karyopharm stock with Overweight rating By Investing.com - Investing.com South Africa

Feb 05, 2026

Feb 05, 2026

Karyopharm to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026 - Karyopharm

Feb 05, 2026

Feb 05, 2026

Cancer drug maker Karyopharm to detail 2025 results in Feb. 12 call - Stock Titan

Feb 05, 2026

Feb 05, 2026

Cantor Fitzgerald Initiates Coverage on Karyopharm Therapeutics (NASDAQ:KPTI) - MarketBeat

Feb 05, 2026

Feb 05, 2026

Cantor Fitzgerald initiates Karyopharm stock with Overweight rating - Investing.com India

Feb 05, 2026

Feb 02, 2026

Karyopharm Therapeutics reports inducement grants under Nasdaq Listing Rule - marketscreener.com

Feb 02, 2026

Feb 02, 2026

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule - TradingView

Feb 02, 2026

Feb 02, 2026

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Feb 02, 2026

Feb 01, 2026

FOMO Trade: How sensitive is Karyopharm Therapeutics Inc to inflationJuly 2025 Highlights & High Accuracy Investment Signals - baoquankhu1.vn

Feb 01, 2026

Feb 01, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Up 110.2% in January - Defense World

Feb 01, 2026

Jan 30, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Short Interest Update - MarketBeat

Jan 30, 2026

Jan 30, 2026

Abate, Karyopharm Therapeutics CAO, sells $351 in stock By Investing.com - Investing.com UK

Jan 30, 2026

Jan 29, 2026

Abate, Karyopharm Therapeutics CAO, sells $351 in stock - Investing.com

Jan 29, 2026

Jan 29, 2026

Myelofibrosis Clinical Trials Outlook: Competitive Intelligence, Regulatory Progress, Emerging Therapies, Mechanisms of Action, and Administration Pathways – DelveInsight - Barchart.com

Jan 29, 2026

Jan 27, 2026

Portfolio Update: mơ công an bắt xeQuarterly Earnings Report & Proven Capital Preservation Methods - baoquankhu1.vn

Jan 27, 2026

Jan 27, 2026

Karyopharm Therapeutics (NASDAQ:KPTI) Shares Pass Below 50-Day Moving AverageHere's What Happened - MarketBeat

Jan 27, 2026

Jan 26, 2026

Can Karyopharm Unlock Xpovio's Growth In 2026 With Pivotal Myelofibrosis Data Ahead? - RTTNews

Jan 26, 2026

Jan 23, 2026

How New Price Targets Are Shaping The Story For Karyopharm Therapeutics (KPTI) - Yahoo Finance

Jan 23, 2026

Jan 23, 2026

Abate, Karyopharm Therapeutics CAO, sells $1.6k in stock By Investing.com - Investing.com UK

Jan 23, 2026

Jan 23, 2026

Abate, Karyopharm Therapeutics CAO, sells $1.6k in stock - Investing.com

Jan 23, 2026

Jan 20, 2026

RBC Raises Price Target on Karyopharm Therapeutics to $23 From $19, Keeps Outperform Rating - marketscreener.com

Jan 20, 2026

Jan 18, 2026

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 18, 2026

Jan 18, 2026

Aug Spikes: Can Karyopharm Therapeutics Inc disrupt its industryDividend Hike & Verified Entry Point Signals - baoquankhu1.vn

Jan 18, 2026

Jan 16, 2026

Chart Watch: Will Karyopharm Therapeutics Inc outperform its industry peersJuly 2025 Intraday Action & Technical Pattern Alert System - baoquankhu1.vn

Jan 16, 2026

Jan 13, 2026

Options Flow: Will Karyopharm Therapeutics Inc 25K0 stock rise with strong economyWeekly Risk Summary & Safe Entry Zone Tips - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Layoff Watch: What margin trends mean for Karyopharm Therapeutics Inc stockWeekly Stock Analysis & Accurate Intraday Trading Signals - Bộ Nội Vụ

Jan 13, 2026

Jan 13, 2026

Analysts Are Bullish on Top Healthcare Stocks: Karyopharm Therapeutics (KPTI), Establishment Labs Holdings (ESTA) - The Globe and Mail

Jan 13, 2026

Jan 13, 2026

Karyopharm expects phase 3 trial data in myelofibrosis by March - Investing.com Canada

Jan 13, 2026